查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1701870

2025 年至 2033 年重组蛋白市场报告（按产品、应用、最终用户和地区）

Recombinant Protein Market Report by Product, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球重组蛋白市场规模达 21 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 50 亿美元，2025-2033 年期间的成长率 (CAGR) 为 9.55%。

重组蛋白是指由重组DNA编码的经过修饰或改变的蛋白质。重组 DNA 分子由质粒组成，其中克隆了目标蛋白质的基因。它是透过分子克隆或聚合酶炼式反应（PCR）产生的。一些常见的产品变体包括激酶蛋白、人类胰岛素、结构蛋白、黏附分子和受体、免疫反应蛋白等。重组蛋白主要用于开发慢性和罕见疾病的新疗法。它在众多生物製药公司、学术和研究机构、合约研究组织等中得到广泛应用。

重组蛋白市场趋势：

多种慢性疾病的盛行率不断上升以及对新型治疗方案的需求不断增加是推动全球重组蛋白市场发展的主要因素。除此之外，蛋白质工程领域的投资不断增加以及对蛋白质药物开发的关注度不断提高，进一步促进了市场的成长。此外，许多政府机构正在资助引进蛋白质体学和基因组学先进技术的研发活动，这对全球重组蛋白市场产生了重大影响。除此之外，重组蛋白表现技术的出现促进了在免疫治疗程序中广泛使用的高品质自体抗原的开发。此外，药物研发领域对重组蛋白进行精确测量的需求不断增长，也为全球市场创造了积极的前景。除此之外，最新分子生物学方法在生物製药中的渗透率不断提高，以减少重组蛋白的蛋白水解或防止糖基化的部分或全部损失，预计将在预测期内提振全球重组蛋白市场。

本报告回答的关键问题

  • 2024 年全球重组蛋白市场规模？ 2025-2033年全球重组蛋白市场的预期成长率是多少？
  • 推动全球重组蛋白市场发展的关键因素有哪些？
  • COVID-19 对全球重组蛋白市场有何影响？
  • 根据应用，全球重组蛋白市场是如何分布的？
  • 根据最终用户，全球重组蛋白市场的分布如何？
  • 全球重组蛋白市场的主要区域有哪些？
  • 全球重组蛋白市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球重组蛋白市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 抗体
  • 荷尔蒙
  • 生长因子
  • 细胞因子
  • 其他的

第七章：市场区隔：依应用

  • 药物研发
  • 学术研究
  • 生物技术研究
  • 生物製药生产
  • 其他的

第八章：市场区隔：按最终用户

  • 製药和生物製药公司
  • 生技公司
  • 学术和研究机构
  • 合约研究组织
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abcam plc
    • Amgen Inc.
    • Bio-RAD Laboratories Inc.
    • Bio-Techne Corporation
    • Bps Bioscience Inc.
    • Enzo Biochem Inc.
    • Genscript Biotech Corporation
    • Merck KGaA
    • Novo Nordisk A/S
    • ProSpec-Tany TechnoGene Ltd
    • Sanofi SA
    • Thermo Fisher Scientific
Product Code: SR112025A6079

The global recombinant protein market size reached USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.55% during 2025-2033.

A recombinant protein refers to a modified or altered protein that is encoded by recombinant DNA. The recombinant DNA molecule consists of a plasmid in which the genes for a target protein are cloned. It is produced either by molecular cloning or polymerase chain reaction (PCR). Some of the common product variants include kinase proteins, human insulin, structural proteins, adhesion molecules and receptors, immune response proteins, etc. Recombinant protein is primarily utilized in the development of novel therapies for chronic and rare diseases. It finds widespread adoption in numerous biopharmaceutical companies, academic and research institutes, contract research organizations, etc.

Recombinant Protein Market Trends:

The elevating prevalence of several chronic diseases along with the increasing demand for novel treatment options is primarily driving the global recombinant protein market. In addition to this, the rising investments in the field of protein engineering and the improving focus on protein-based drug development are further augmenting the market growth. Moreover, numerous government bodies are funding R&D activities for the introduction of advanced techniques in proteomics and genomics, which are significantly impacting the global market for recombinant protein. Besides this, the advent of recombinant protein expression technology has led to the development of high-quality autoantigens that are widely used in immunotherapy procedures. Additionally, the growing requirement for recombinant proteins for accurate measurement of biomarkers in the field of drug discovery is also creating a positive outlook for the global market. Apart from this, the rising penetration of latest molecular biology approaches for biopharming to reduce proteolysis of recombinant proteins or prevent the partial or total loss of glycosylation is expected to bolster the global recombinant protein market over the forecast period.

Key Market Segmentation:

Breakup by Product:

  • Antibodies
  • Hormones
  • Growth Factors
  • Cytokines
  • Others

Breakup by Application:

  • Drug Discovery and Development
  • Academic Research
  • Biotechnology Research
  • Biopharmaceutical Production
  • Others

Breakup by End User:

  • Pharmaceutical and Biopharmaceutical Companies
  • Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organization
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Amgen Inc., Bio-RAD Laboratories Inc., Bio-Techne Corporation, Bps Bioscience Inc., Enzo Biochem Inc., Genscript Biotech Corporation, Merck KGaA, Novo Nordisk A/S, ProSpec-Tany TechnoGene Ltd, Sanofi S.A. and Thermo Fisher Scientific.

Key Questions Answered in This Report

  • 1.What was the size of the global recombinant protein market in 2024?
  • 2.What is the expected growth rate of the global recombinant protein market during 2025-2033?
  • 3.What are the key factors driving the global recombinant protein market?
  • 4.What has been the impact of COVID-19 on the global recombinant protein market?
  • 5.What is the breakup of the global recombinant protein market based on application?
  • 6.What is the breakup of the global recombinant protein market based on the end user?
  • 7.What are the key regions in the global recombinant protein market?
  • 8.Who are the key players/companies in the global recombinant protein market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Recombinant Protein Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Antibodies
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hormones
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Growth Factors
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cytokines
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Drug Discovery and Development
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Academic Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biotechnology Research
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Biopharmaceutical Production
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical and Biopharmaceutical Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic and Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Contract Research Organization
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bio-RAD Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Techne Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Bps Bioscience Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Enzo Biochem Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Genscript Biotech Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Novo Nordisk A/S
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 ProSpec-Tany TechnoGene Ltd
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Sanofi S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Recombinant Protein Market: Major Drivers and Challenges
  • Figure 2: Global: Recombinant Protein Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Recombinant Protein Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Recombinant Protein Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Recombinant Protein Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Recombinant Protein Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Recombinant Protein Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Recombinant Protein (Antibodies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Recombinant Protein (Antibodies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Recombinant Protein (Hormones) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Recombinant Protein (Hormones) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Recombinant Protein (Growth Factors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Recombinant Protein (Growth Factors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Recombinant Protein (Cytokines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Recombinant Protein (Cytokines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Recombinant Protein (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Recombinant Protein (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Recombinant Protein (Drug Discovery and Development) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Recombinant Protein (Drug Discovery and Development) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Recombinant Protein (Academic Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Recombinant Protein (Academic Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Recombinant Protein (Biotechnology Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Recombinant Protein (Biotechnology Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Recombinant Protein (Biopharmaceutical Production) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Recombinant Protein (Biopharmaceutical Production) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Recombinant Protein (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Recombinant Protein (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Recombinant Protein (Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Recombinant Protein (Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Recombinant Protein (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Recombinant Protein (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Recombinant Protein (Contract Research Organization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Recombinant Protein (Contract Research Organization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Recombinant Protein (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Recombinant Protein (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: North America: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: North America: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: United States: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: United States: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Canada: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Canada: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Asia-Pacific: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Asia-Pacific: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: China: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: China: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Japan: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Japan: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: India: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: India: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: South Korea: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: South Korea: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Australia: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Australia: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Indonesia: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Indonesia: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Europe: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Europe: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Germany: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Germany: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: France: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: France: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: United Kingdom: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: United Kingdom: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Italy: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Italy: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Spain: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Spain: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Russia: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Russia: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Latin America: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Latin America: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Brazil: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Brazil: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Mexico: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Mexico: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Others: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Others: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Middle East and Africa: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Middle East and Africa: Recombinant Protein Market: Breakup by Country (in %), 2024
  • Figure 86: Middle East and Africa: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Global: Recombinant Protein Industry: SWOT Analysis
  • Figure 88: Global: Recombinant Protein Industry: Value Chain Analysis
  • Figure 89: Global: Recombinant Protein Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Recombinant Protein Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Recombinant Protein Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Recombinant Protein Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Recombinant Protein Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Recombinant Protein Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Recombinant Protein Market: Competitive Structure
  • Table 7: Global: Recombinant Protein Market: Key Players